| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase.
|
J Clin Endocrinol Metab
|
2001
|
4.47
|
|
2
|
Local and systemic glucocorticoid metabolism in inflammatory arthritis.
|
Ann Rheum Dis
|
2008
|
1.86
|
|
3
|
Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney.
|
J Am Soc Nephrol
|
1999
|
1.47
|
|
4
|
Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.
|
Gut
|
2004
|
1.43
|
|
5
|
Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase.
|
Arch Biochem Biophys
|
2012
|
1.41
|
|
6
|
Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway.
|
Biol Reprod
|
2008
|
1.37
|
|
7
|
Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells.
|
FASEB J
|
2006
|
1.31
|
|
8
|
Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase.
|
Endocrinology
|
1999
|
1.29
|
|
9
|
Vitamin D, the placenta and pregnancy.
|
Arch Biochem Biophys
|
2011
|
1.28
|
|
10
|
Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines.
|
Endocrinology
|
2001
|
1.24
|
|
11
|
Reduced placental 11beta-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms.
|
J Clin Endocrinol Metab
|
2001
|
1.21
|
|
12
|
Dendritic cells from human tissues express receptors for the immunoregulatory vitamin D3 metabolite, dihydroxycholecalciferol.
|
Immunology
|
1987
|
1.20
|
|
13
|
Regulation of human tonsillar T-cell proliferation by the active metabolite of vitamin D3.
|
Immunology
|
1986
|
1.19
|
|
14
|
Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
|
J Clin Endocrinol Metab
|
2002
|
1.17
|
|
15
|
Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia.
|
Bone
|
1996
|
1.13
|
|
16
|
Expression of type 2 11beta-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life.
|
J Clin Endocrinol Metab
|
1998
|
1.13
|
|
17
|
Glucocorticoid activity, inactivity and the osteoblast.
|
J Endocrinol
|
1999
|
1.11
|
|
18
|
Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation.
|
J Bone Miner Res
|
2001
|
1.11
|
|
19
|
Loss of estrogen inactivation in colonic cancer.
|
J Clin Endocrinol Metab
|
1999
|
1.06
|
|
20
|
11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation.
|
Mol Endocrinol
|
2004
|
1.05
|
|
21
|
Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production.
|
Endocrinology
|
2007
|
1.03
|
|
22
|
Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3.
|
J Clin Invest
|
1993
|
1.00
|
|
23
|
Mutations in the vitamin D receptor gene in three kindreds associated with hereditary vitamin D resistant rickets.
|
J Clin Endocrinol Metab
|
1997
|
1.00
|
|
24
|
Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation.
|
Oncogene
|
2003
|
0.99
|
|
25
|
Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease.
|
Postgrad Med J
|
1990
|
0.99
|
|
26
|
Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone.
|
Bone
|
2000
|
0.97
|
|
27
|
11beta-hydroxysteroid dehydrogenases, cell proliferation and malignancy.
|
J Steroid Biochem Mol Biol
|
2003
|
0.96
|
|
28
|
Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye.
|
Invest Ophthalmol Vis Sci
|
2001
|
0.95
|
|
29
|
Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1.
|
J Biol Chem
|
2001
|
0.93
|
|
30
|
Estrone potentiates myeloid cell differentiation: a role for 17 beta-hydroxysteroid dehydrogenase in modulating hemopoiesis.
|
Exp Hematol
|
1999
|
0.93
|
|
31
|
Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in subcutaneous fat necrosis.
|
Br J Dermatol
|
2008
|
0.93
|
|
32
|
Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase along the nephron: new insights into renal vitamin D metabolism.
|
Curr Opin Nephrol Hypertens
|
2000
|
0.92
|
|
33
|
Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function.
|
J Cell Biochem
|
1999
|
0.91
|
|
34
|
Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss.
|
Ann Rheum Dis
|
2009
|
0.90
|
|
35
|
Characterization of 11beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines.
|
J Endocrinol
|
1999
|
0.90
|
|
36
|
Vitamin D-dependent rickets type II in a cat.
|
J Small Anim Pract
|
2005
|
0.89
|
|
37
|
Presentation of a PTHrP-secreting pancreatic neuroendocrine tumour, with hypercalcaemic crisis, pre-eclampsia, and renal failure.
|
Postgrad Med J
|
2002
|
0.89
|
|
38
|
Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
|
Endocrinology
|
1999
|
0.88
|
|
39
|
Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping.
|
Clin Endocrinol (Oxf)
|
1996
|
0.88
|
|
40
|
Estrogen metabolism and malignancy: analysis of the expression and function of 17beta-hydroxysteroid dehydrogenases in colonic cancer.
|
Mol Cell Endocrinol
|
2001
|
0.86
|
|
41
|
Regulation of 11 beta-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes.
|
J Endocrinol
|
1998
|
0.86
|
|
42
|
Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures.
|
Clin Endocrinol (Oxf)
|
1994
|
0.86
|
|
43
|
Association studies between microsatellite markers within the gene encoding human 11beta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism.
|
J Clin Endocrinol Metab
|
2002
|
0.86
|
|
44
|
Vitamin D and hematopoiesis.
|
Trends Endocrinol Metab
|
1997
|
0.85
|
|
45
|
The renal function of 25-hydroxyvitamin D3-1alpha-hydroxylase.
|
Mol Cell Endocrinol
|
1999
|
0.84
|
|
46
|
1,25-dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes.
|
Endocrinology
|
1997
|
0.83
|
|
47
|
Effects of 1,25-dihydroxyvitamin D3 and cortisol on bovine and human parathyroid cells.
|
J Endocrinol
|
1989
|
0.82
|
|
48
|
Regulation of vitamin D-1alpha-hydroxylase in a human cortical collecting duct cell line.
|
Kidney Int
|
2001
|
0.82
|
|
49
|
1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes.
|
Immunology
|
1991
|
0.82
|
|
50
|
Progesterone is extensively metabolized in osteoblasts: implications for progesterone action on bone.
|
Horm Metab Res
|
2008
|
0.81
|
|
51
|
Immunodetection of 11 beta-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissues: evidence for nuclear localization.
|
Endocrinology
|
1997
|
0.81
|
|
52
|
Binding of the receptor for 1,25-dihydroxyvitamin D3 to the 5'-flanking region of the bovine parathyroid hormone gene.
|
J Endocrinol
|
1990
|
0.79
|
|
53
|
Expression of 11 beta-hydroxysteroid dehydrogenase in rat osteoblastic cells: pre-receptor regulation of glucocorticoid responses in bone.
|
J Cell Biochem
|
2001
|
0.79
|
|
54
|
Oestrogen inactivation in the colon: analysis of the expression and regulation of 17beta-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer.
|
Br J Cancer
|
2000
|
0.78
|
|
55
|
Co-chaperone potentiation of vitamin D receptor-mediated transactivation: a role for Bcl2-associated athanogene-1 as an intracellular-binding protein for 1,25-dihydroxyvitamin D3.
|
J Mol Endocrinol
|
2007
|
0.78
|
|
56
|
Clofibric acid: a potential therapeutic agent in AML and MDS.
|
Br J Haematol
|
1999
|
0.78
|
|
57
|
Expression of 11 beta-hydroxysteroid dehydrogenase isozymes and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies.
|
Mol Hum Reprod
|
2001
|
0.77
|
|
58
|
Characterization of aromatase and 17 beta-hydroxysteroid dehydrogenase expression in rat osteoblastic cells.
|
J Bone Miner Res
|
1998
|
0.77
|
|
59
|
Differential RNA display identifies novel genes associated with decreased vitamin D receptor expression.
|
Mol Cell Endocrinol
|
1998
|
0.77
|
|
60
|
Selenium and heavy metals.
|
Ann Clin Res
|
1986
|
0.77
|
|
61
|
Differential expression of nuclear 11beta-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues.
|
Endocrinology
|
1997
|
0.76
|
|
62
|
Characterization of human trophoblast as a mineralocorticoid target tissue.
|
Mol Hum Reprod
|
2003
|
0.76
|
|
63
|
Steroid hormone metabolites and hormone binding assays.
|
Methods Mol Biol
|
2001
|
0.75
|
|
64
|
Cell mates in the superfamily.
|
Endocrinology
|
1994
|
0.75
|